home / stock / hart / hart news


HART News and Press, IQ Healthy Hearts ETF From 06/25/22

Stock Information

Company Name: IQ Healthy Hearts ETF
Stock Symbol: HART
Market: NYSE

Menu

HART HART Quote HART Short HART News HART Articles HART Message Board
Get HART Alerts

News, Short Squeeze, Breakout and More Instantly...

HART - Taking Stock: Q3 2022 Equity Market Outlook

The first five months of the year marked the worst start for the S&P 500 since 1970 ― and the sixth worst back to 1928. Stock valuations have come down, but company earnings remain solid. Earnings will slow, but 20% is hard to imagine, even in a recession. For fur...

HART - Medifast And Its Real Value

Medifast, Inc. is a fast-growing company that continues to generate increasing profits and excellent returns for investors. In addition to solid growth, the company offers a hefty dividend. The sales model that has driven its profitability is also one that could raise concerns for...

HART - Shifting Opportunities In An Atypical Landscape

How similar will the next three or five years look from the years that immediately preceded the pandemic? And what are the implications for us as global equity investors? We don’t expect anything like the hyperinflation and stagflation we experienced in the 1970s; our outlook s...

HART - Top Golf's Wide Moat Gives Callaway Upside

Callaway is an industry leader in golf equipment, apparel, and family entertainment. ELY had a strong start to FY22, with Q1 earnings having an EPS beat of 33%. Top Golf is the only family entertainment experience of its kind with a wide moat. Using very conservative estimates...

HART - Peloton: Down 80% In 6 Months, But Don't Buy This Dip, Avoid

Peloton's stock is down 80% in 6 months. As I've been arguing consistently, avoid this name. Peloton doesn't just burn calories. It also burns through cash. A lot of cash. In fact, it burns 79 cents of free cash flow for every $1 of revenue. Peloton is a stock that I've declared t...

HART - Defensive Value: The Safety Trade Of 2022

Healthcare, Staples, and Utilities continue to outperform as selling intensifies in the growth style. Investor positioning is still light in the space – even after a year of alpha. While absolute valuations have turned somewhat pricey, the defensive supersector shows decent...

HART - Riders On The Storm

During the last Fed rate raising cycle, it took the Federal Reserve five years to raise the fed funds rate to 2.50%. The Fed kept rates far too low for far too long and now we are dealing with the consequences. Both fiscal and monetary policy have been highly inflationary, and we are ...

HART - Defensives Propping Up New Highs

Typically, we look at net new highs as a way to confirm moves in the broader market. At the high last Wednesday, over 90% of S&P 500’s new highs came from defensive sectors. In other words, defensives have been a notable pocket of strength recently. For further de...

HART - Equity Outlook: War Intensifies Inflation Test For Investors

Stock markets fell in the first quarter as Russia’s invasion of Ukraine destabilized the growth outlook, amplified concerns about rising interest rates and unleashed geopolitical risks. While the conflict has created many uncertainties, we believe the impact of persistent infla...

HART - Biopharma's Public Money And Private Money

The XBI biotech index peaked early last year, and it's now back to where it was in April of 2020. The biopharma stocks got powerfully inflated during 2020 by the pandemic. The biotech stocks are going to need some good news to get moving again. For further details see: B...

Previous 10 Next 10